Cardiometabolic Monitoring Products Market Trends & Growth 2024-2031

Cardiometabolic Monitoring Products Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Global Cardiometabolic Monitoring Products Market&nbsp;Size, Share &amp; Trends Analysis Report By Product Type, By Indication, By End-user, By Region, And Segment Forecasts, 2024 &ndash; 2031</h2>

<h3>Market Overview</h3>

<blockquote>
<p>Global Cardiometabolic Monitoring Products Market reached US$ YY&nbsp;million in 2023 and is expected to reach US$&nbsp;million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031</p>
</blockquote>

<p>Cardiometabolic monitoring products are essential tools for tracking and managing health parameters related to cardiovascular and metabolic systems, such as heart disease, diabetes, hypertension, and obesity, which are often interconnected and collectively known as cardiometabolic diseases.&nbsp;</p>

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			<p><strong>Metrics</strong></p>
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			<p><strong>Details</strong></p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			<p><strong>CAGR</strong></p>
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			<p>YY%</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Market Size Available for Years</strong></p>
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>2022-2031</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Estimation Forecast Period</strong></p>
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>2024-2031</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Revenue Units</strong></p>
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>Value (US$ Mn)&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Segments Covered</strong></p>
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>Product Type, Indication, End User</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Regions Covered</strong></p>
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Largest Region</strong></p>
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>North America</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Fastest Growing Region</strong></p>
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>Asia-Pacific</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Report Insights Covered</strong></p>
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.</p>
			</td>
		</tr>
	</tbody>
</table>

<p><br />
&nbsp;</p>

<p><strong>For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/cardiometabolic-monitoring-products-market" target="_blank">Request for Sample</a></strong></p>

<h3>&nbsp;</h3>

<h3>Market Dynamics: Drivers &amp; Restraints</h3>

<p><strong>Rise in the prevalence of cardiovascular diseases</strong></p>

<p>Cardiometabolic disorders (CMDs) are the leading cause of death worldwide. Cardiovascular disease (CVD), diabetes mellitus, and chronic renal failure are examples. CMDs are mostly caused by an unhealthy lifestyle, with physical inactivity, smoking, and an improper diet being key risk factors.</p>

<p>For instance, according to WHO, cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. More than four out of five CVD deaths are due to heart attacks and strokes, and one-third of these deaths occur prematurely in people under 70 years of age.</p>

<p><strong>High cost of devices</strong></p>

<p>Advanced cardiometabolic monitoring devices, like continuous glucose monitors and multi-parameter monitors, can be costly for healthcare providers and patients due to their high initial investment and ongoing expenses for consumables like test strips and sensors. Moreover, factors like, regulatory and compliance issue, limited reimbursement policies, data privacy and security conerns and among others hinder the market during the forecast period.</p>

<h3>Segment Analysis</h3>

<p>The global cardiometabolic monitoring products market is segmented based on product type, indication, end-user and region.</p>

<p><strong>The blood glucose monitors from the product type segment accounted for approximately 37.3% of the cardiometabolic monitoring products&nbsp; market share</strong></p>

<p>The blood glucose monitors from the product type segment accounted for approximately 37.3%. Blood glucose monitors are a critical component of cardiometabolic monitoring products, playing a vital role in the management of diabetes and related metabolic disorders. These devices measure the concentration of glucose in the blood, providing essential information for the management of diabetes and helping to prevent complications associated with both high and low blood sugar levels.</p>

<p>For instance, in June 2024, Prevounce Health launched Pylo GL1-LTE, a cellular-connected remote blood glucose meter for remote monitoring of patients. This new clinically validated device is designed to enhance remote patient monitoring (RPM) programmes for diabetes management by ensuring reliable data transmission across the US.</p>

<h3>Geographical Analysis</h3>

<p><strong>North America is estimated to hold about 38.4% of the total market share throughout the forecast period</strong><strong> </strong></p>

<p>North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like the novel product launches, FDA approvals, collaborations, advanced healthcare infrastructure in the region and other factors help the region to grow during the forecast period.</p>

<p>For instance, in February 2024, Neomorph announced Multi-Target Collaboration with Novo Nordisk to Discover Novel Molecular Glue Degraders for Cardiometa Under the terms of the agreement, Neomorph will receive an upfront and near-term milestone payments, plus R&amp;D funding. Neomorph is also eligible to receive future clinical, commercial and sales milestone payments bringing the total potential deal value for multiple targets to $1.46B, plus tiered royalties.</p>

<h3>Covid 19 Impact Analysis</h3>

<p>The COVID-19 pandemic has worsened cardiometabolic health at the population level due to factors like reduced physical activity, poor diet, and increased stress, increasing the risk of cardiometabolic diseases. The strain on healthcare systems disrupted routine monitoring and management of cardiometabolic conditions, potentially impacting population health.&nbsp;</p>

<h3>Market Segmentation</h3>

<p>By Product Type</p>

<ul>
	<li>Blood Glucose Monitors</li>
	<li>Blood Pressure Monitors</li>
	<li>POC Analysers</li>
	<li>Cholesterol Analyser</li>
	<li>Holter monitor</li>
	<li>ECG</li>
	<li>Others</li>
</ul>

<p>By Indication</p>

<ul>
	<li>Cardiovascular Diseases</li>
	<li>Metabolic Disorders</li>
	<li>Others</li>
</ul>

<p>By End-User</p>

<ul>
	<li>Hospitals</li>
	<li>Diagnostic Centers</li>
	<li>Ambulatory Surgical Centers</li>
	<li>Others&nbsp;</li>
</ul>

<p>By Region</p>

<ul>
	<li>North America
	<ul>
		<li>U.S.</li>
		<li>Canada</li>
		<li>Mexico</li>
	</ul>
	</li>
	<li>Europe
	<ul>
		<li>Germany</li>
		<li>UK</li>
		<li>France</li>
		<li>Italy</li>
		<li>Spain</li>
		<li>Rest of Europe</li>
	</ul>
	</li>
	<li>South America
	<ul>
		<li>Brazil</li>
		<li>Argentina</li>
		<li>Rest of South America</li>
	</ul>
	</li>
	<li>Asia-Pacific
	<ul>
		<li>China</li>
		<li>India</li>
		<li>Japan</li>
		<li>South Korea</li>
		<li>Rest of Asia-Pacific</li>
	</ul>
	</li>
	<li>Middle East and Africa</li>
</ul>

<h3>Competitive Landscape</h3>

<p>The major global players in the market include Abbott Laboratories, Medtronic Plc, Jana Care, Johnson &amp; Johnson, GE Healthcare, Omron Healthcare, Philips Healthcare, Dexcom, Roche Diagnostics, Bayer AG among others.</p>

<h3>Key Developments</h3>

<ul>
	<li>In May 2024, Beurer India Pvt. Ltd, the manufacturer of electric healthtech devices, announced the launch of a blood glucose monitor device retailing for ₹1,200, which will be available in the market by September 2024.</li>
	<li>In October 2023, Better Therapeutics, Inc., a pioneer in developing prescription digital therapeutics (PDTs) to treat cardiometabolic diseases, announced the commercial launch of AspyreRx, the first cognitive behavioural therapy (CBT) app to receive U.S Food and Drug Administration (FDA) authorization as a Class II device to treat adults with type 2 diabetes (T2D).</li>
</ul>

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global cardiometabolic monitoring products market segmentation based on product type, indication, end user and region as well as understand key commercial assets and players.</li>
	<li>identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>excel data sheet with numerous data points of the cardiometabolic monitoring products market level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

<p><strong><em>The global cardiometabolic monitoring products market report would provide approximately 64 tables, 61 figures and 186 pages.</em></strong></p>

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>


<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Product Type</li>
		<li>Snippet by Indication</li>
		<li>Snippet by End User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rise in&nbsp; the prevalence of cardiovascular diseases</li>
				<li>Rise of technological advancement in the devices</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>High cost of devices</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Patent Analysis</li>
		<li>PESTLE Analysis</li>
		<li>SWOT Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By&nbsp; Product Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Attractiveness Index, By Product Type</li>
		</ol>
		</li>
		<li>Blood Glucose Monitors *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Blood Pressure Monitors</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">POC Analysers</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Cholesterol Analyser</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Holter monitor</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">ECG</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Others&nbsp;</h3>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Indication</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Attractiveness Index, By Indication</li>
		</ol>
		</li>
		<li>Cardiovascular Diseases *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Metabolic Disorders</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Others</h3>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Attractiveness Index, By End User</li>
		</ol>
		</li>
		<li>Hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Diagnostic Centers</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Ambulatory Surgical Centers</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Others&nbsp;</h3>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>South Korea</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Abbott Laboratories*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Medtronic Plc</li>
		<li>Jana Care</li>
		<li>Johnson &amp; Johnson</li>
		<li>GE Healthcare</li>
		<li>Omron Healthcare</li>
		<li>Philips Healthcare</li>
		<li>Dexcom</li>
		<li>Roche Diagnostics</li>
		<li>Bayer AG&nbsp;(<em>LIST NOT EXHAUSTIVE)&nbsp;</em></li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>


<p><strong>List of Tables</strong></p>

<p>Table 1 Global Cardiometabolic Monitoring Products Market Value, By Product Type, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 2 Global Cardiometabolic Monitoring Products Market Value, By Indication, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 3 Global Cardiometabolic Monitoring Products Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 4 Global Cardiometabolic Monitoring Products Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 5 Global Cardiometabolic Monitoring Products Market Value, By Product Type, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 6 Global Cardiometabolic Monitoring Products Market Value, By Product Type, 2022-2031 (US$ Million)</p>

<p>Table 7 Global Cardiometabolic Monitoring Products Market Value, By Indication, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 8 Global Cardiometabolic Monitoring Products Market Value, By Indication, 2022-2031 (US$ Million)</p>

<p>Table 9 Global Cardiometabolic Monitoring Products Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 10 Global Cardiometabolic Monitoring Products Market Value, By End-User, 2022-2031 (US$ Million)</p>

<p>Table 11 Global Cardiometabolic Monitoring Products Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 12 Global Cardiometabolic Monitoring Products Market Value, By Region, 2022-2031 (US$ Million)</p>

<p>Table 13 North America Cardiometabolic Monitoring Products Market Value, By Product Type, 2022-2031 (US$ Million)</p>

<p>Table 14 North America Cardiometabolic Monitoring Products Market Value, By Indication, 2022-2031 (US$ Million)</p>

<p>Table 15 North America Cardiometabolic Monitoring Products Market Value, By End-User, 2022-2031 (US$ Million)</p>

<p>Table 16 North America Cardiometabolic Monitoring Products Market Value, By Country, 2022-2031 (US$ Million)</p>

<p>Table 17 Asia-Pacific Cardiometabolic Monitoring Products Market Value, By Product Type, 2022-2031 (US$ Million)</p>

<p>Table 18 Asia-Pacific Cardiometabolic Monitoring Products Market Value, By Indication, 2022-2031 (US$ Million)</p>

<p>Table 19 Asia-Pacific Cardiometabolic Monitoring Products Market Value, By End-User, 2022-2031 (US$ Million)</p>

<p>Table 20 Asia-Pacific Cardiometabolic Monitoring Products Market Value, By Country, 2022-2031 (US$ Million)</p>

<p>Table 21 Europe Cardiometabolic Monitoring Products Market Value, By Product Type, 2022-2031 (US$ Million)</p>

<p>Table 22 Europe Cardiometabolic Monitoring Products Market Value, By Indication, 2022-2031 (US$ Million)</p>

<p>Table 23 Europe Cardiometabolic Monitoring Products Market Value, By End-User, 2022-2031 (US$ Million)</p>

<p>Table 24 Europe Cardiometabolic Monitoring Products Market Value, By Country, 2022-2031 (US$ Million)</p>

<p>Table 25 South America Cardiometabolic Monitoring Products Market Value, By Product Type, 2022-2031 (US$ Million)</p>

<p>Table 26 South America Cardiometabolic Monitoring Products Market Value, By Indication, 2022-2031 (US$ Million)</p>

<p>Table 27 South America Cardiometabolic Monitoring Products Market Value, By End-User, 2022-2031 (US$ Million)</p>

<p>Table 28 South America Cardiometabolic Monitoring Products Market Value, By Country, 2022-2031 (US$ Million)</p>

<p>Table 29 Middle East and Africa Cardiometabolic Monitoring Products Market Value, By Product Type, 2022-2031 (US$ Million)</p>

<p>Table 30 Middle East and Africa Cardiometabolic Monitoring Products Market Value, By Indication, 2022-2031 (US$ Million)</p>

<p>Table 31 Middle East and Africa Cardiometabolic Monitoring Products Market Value, By End-User, 2022-2031 (US$ Million)</p>

<p>Table 32 Middle East and Africa Cardiometabolic Monitoring Products Market Value, By Country, 2022-2031 (US$ Million)</p>

<p>Table 33 Abbott Laboratories: Overview</p>

<p>Table 34 Abbott Laboratories: Product Portfolio</p>

<p>Table 35 Abbott Laboratories: Key Developments</p>

<p>Table 36 Medtronic Plc: Overview</p>

<p>Table 37 Medtronic Plc: Product Portfolio</p>

<p>Table 38 Medtronic Plc: Key Developments</p>

<p>Table 39 Jana Care: Overview</p>

<p>Table 40 Jana Care: Product Portfolio</p>

<p>Table 41 Jana Care: Key Developments</p>

<p>Table 42 Johnson &amp; Johnson: Overview</p>

<p>Table 43 Johnson &amp; Johnson: Product Portfolio</p>

<p>Table 44 Johnson &amp; Johnson: Key Developments</p>

<p>Table 45 GE Healthcare: Overview</p>

<p>Table 46 GE Healthcare: Product Portfolio</p>

<p>Table 47 GE Healthcare: Key Developments</p>

<p>Table 48 Omron Healthcare: Overview</p>

<p>Table 49 Omron Healthcare: Product Portfolio</p>

<p>Table 50 Omron Healthcare: Key Developments</p>

<p>Table 51 Philips Healthcare: Overview</p>

<p>Table 52 Philips Healthcare: Product Portfolio</p>

<p>Table 53 Philips Healthcare: Key Developments</p>

<p>Table 54 Dexcom: Overview</p>

<p>Table 55 Dexcom: Product Portfolio</p>

<p>Table 56 Dexcom: Key Developments</p>

<p>Table 57 Roche Diagnostics: Overview</p>

<p>Table 58 Roche Diagnostics: Product Portfolio</p>

<p>Table 59 Roche Diagnostics: Key Developments</p>

<p>Table 60 Bayer AG: Overview</p>

<p>Table 61 Bayer AG: Product Portfolio</p>

<p>Table 62 Bayer AG: Key Developments</p>

<p><strong>List of Figures</strong></p>

<p>Figure 1 Global Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 2 Global Cardiometabolic Monitoring Products Market Share, By Product Type, 2023 &amp; 2031 (%)</p>

<p>Figure 3 Global Cardiometabolic Monitoring Products Market Share, By Indication, 2023 &amp; 2031 (%)</p>

<p>Figure 4 Global Cardiometabolic Monitoring Products Market Share, By End-User, 2023 &amp; 2031 (%)</p>

<p>Figure 5 Global Cardiometabolic Monitoring Products Market Share, By Region, 2023 &amp; 2031 (%)</p>

<p>Figure 6 Global Cardiometabolic Monitoring Products Market Y-o-Y Growth, By Product Type, 2023-2031 (%)</p>

<p>Figure 7 Blood Glucose Monitors Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 8 Blood Pressure Monitors Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 9 POC Analysers Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 10 Cholesterol Analyser Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 11 Holter monitor Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 12 ECG Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 13 Others Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 14 Global Cardiometabolic Monitoring Products Market Y-o-Y Growth, By Indication, 2023-2031 (%)</p>

<p>Figure 15 Cardiovascular Diseases Indication in Global Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 16 Metabolic Disorders Indication in Global Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 17 Others Indication in Global Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 18 Global Cardiometabolic Monitoring Products Market Y-o-Y Growth, By End-User, 2023-2031 (%)</p>

<p>Figure 19 Hospitals End-User in Global Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 20 Diagnostic Centers End-User in Global Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 21 Ambulatory Surgical Centers End-User in Global Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 22 Others End-User in Global Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 23 Global Cardiometabolic Monitoring Products Market Y-o-Y Growth, By Region, 2023-2031 (%)</p>

<p>Figure 24 North America Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 25 North America Cardiometabolic Monitoring Products Market Share, By Product Type, 2023 &amp; 2031 (%)</p>

<p>Figure 26 North America Cardiometabolic Monitoring Products Market Share, By Indication, 2023 &amp; 2031 (%)</p>

<p>Figure 27 North America Cardiometabolic Monitoring Products Market Share, By End-User, 2023 &amp; 2031 (%)</p>

<p>Figure 28 North America Cardiometabolic Monitoring Products Market Share, By Country, 2023 &amp; 2031 (%)</p>

<p>Figure 29 Asia-Pacific Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 30 Asia-Pacific Cardiometabolic Monitoring Products Market Share, By Product Type, 2023 &amp; 2031 (%)</p>

<p>Figure 31 Asia-Pacific Cardiometabolic Monitoring Products Market Share, By Indication, 2023 &amp; 2031 (%)</p>

<p>Figure 32 Asia-Pacific Cardiometabolic Monitoring Products Market Share, By End-User, 2023 &amp; 2031 (%)</p>

<p>Figure 33 Asia-Pacific Cardiometabolic Monitoring Products Market Share, By Country, 2023 &amp; 2031 (%)</p>

<p>Figure 34 Europe Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 35 Europe Cardiometabolic Monitoring Products Market Share, By Product Type, 2023 &amp; 2031 (%)</p>

<p>Figure 36 Europe Cardiometabolic Monitoring Products Market Share, By Indication, 2023 &amp; 2031 (%)</p>

<p>Figure 37 Europe Cardiometabolic Monitoring Products Market Share, By End-User, 2023 &amp; 2031 (%)</p>

<p>Figure 38 Europe Cardiometabolic Monitoring Products Market Share, By Country, 2023 &amp; 2031 (%)</p>

<p>Figure 39 South America Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 40 South America Cardiometabolic Monitoring Products Market Share, By Product Type, 2023 &amp; 2031 (%)</p>

<p>Figure 41 South America Cardiometabolic Monitoring Products Market Share, By Indication, 2023 &amp; 2031 (%)</p>

<p>Figure 42 South America Cardiometabolic Monitoring Products Market Share, By End-User, 2023 &amp; 2031 (%)</p>

<p>Figure 43 South America Cardiometabolic Monitoring Products Market Share, By Country, 2023 &amp; 2031 (%)</p>

<p>Figure 44 Middle East and Africa Cardiometabolic Monitoring Products Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 45 Middle East and Africa Cardiometabolic Monitoring Products Market Share, By Product Type, 2023 &amp; 2031 (%)</p>

<p>Figure 46 Middle East and Africa Cardiometabolic Monitoring Products Market Share, By Indication, 2023 &amp; 2031 (%)</p>

<p>Figure 47 Middle East and Africa Cardiometabolic Monitoring Products Market Share, By End-User, 2023 &amp; 2031 (%)</p>

<p>Figure 48 Abbott Laboratories: Financials</p>

<p>Figure 49 Medtronic Plc: Financials</p>

<p>Figure 50 Jana Care: Financials</p>

<p>Figure 51 Johnson &amp; Johnson: Financials</p>

<p>Figure 52 GE Healthcare: Financials</p>

<p>Figure 53 Omron Healthcare: Financials</p>

<p>Figure 54 Philips Healthcare: Financials</p>

<p>Figure 55 Dexcom: Financials</p>

<p>Figure 56 Roche Diagnostics: Financials</p>

<p>Figure 57 Bayer AG: Financials</p>
